Followers | 134 |
Posts | 7040 |
Boards Moderated | 0 |
Alias Born | 02/09/2012 |
Saturday, December 09, 2017 2:53:11 PM
We are in blue sky territory. Fundamentals support $200 and upon final approval (likely accelerated) $500, you can throw technicals out. As we approach $200 there will be a big short squeeze ahead of it that could propel to $225..
PS would love to see $130... would go all in with leaps.
Recent SAGE News
- The Gross Law Firm Reminds Sage Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 - SAGE • PR Newswire (US) • 09/23/2024 09:45:00 AM
- The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of October 28, 2024 in Sage Therapeutics, Inc. Lawsuit - SAGE • PR Newswire (US) • 09/19/2024 09:45:00 AM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 09/17/2024 10:33:39 AM
- The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of October 28, 2024 in Sage Therapeutics Lawsuit - SAGE • PR Newswire (US) • 09/16/2024 09:45:00 AM
- Sage Therapeutics, Inc. Class Action: The Gross Law Firm Reminds Sage Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 - SAGE • PR Newswire (US) • 09/12/2024 09:45:00 AM
- Edelson Lechtzin LLP Urges Sage Therapeutics, Inc. (NASDAQ: SAGE) Shareholders to Seek Legal Counsel About the Pending Securities Fraud Class Action • PR Newswire (US) • 09/05/2024 08:03:00 PM
- Sage Therapeutics Inc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SAGE • PR Newswire (US) • 09/05/2024 12:30:00 PM
- Sage Therapeutics Inc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SAGE • PR Newswire (US) • 08/08/2024 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2024 08:05:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2024 08:04:41 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/31/2024 08:15:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2024 08:10:32 PM
- Sage Therapeutics Announces Second Quarter 2024 Financial Results and Highlights Pipeline and Business Progress • Business Wire • 07/31/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/24/2024 10:39:54 AM
- Sage Therapeutics and Biogen Announce Topline Results from Phase 2 KINETIC 2 Study of SAGE-324 (BIIB124) for the Treatment of Essential Tremor • Business Wire • 07/24/2024 10:30:00 AM
- Sage Therapeutics to Report Second Quarter 2024 Financial Results on Wednesday, July 31, 2024 • Business Wire • 07/17/2024 10:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/11/2024 08:57:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/11/2024 08:57:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2024 08:16:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2024 10:45:00 AM
- Sage Therapeutics Announces Phase 2 SURVEYOR Study Reinforces Cognitive Impact of Huntington’s Disease • Business Wire • 06/11/2024 10:30:00 AM
- Sage Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference • Business Wire • 06/05/2024 10:30:00 AM
- Sage Therapeutics to Participate in Upcoming May Investor Conferences • Business Wire • 05/07/2024 10:30:00 AM
- Sage Therapeutics Announces First Quarter 2024 Financial Results and Highlights Pipeline and Business Progress • Business Wire • 04/25/2024 10:30:00 AM
- Sage Therapeutics Announces Topline Results from Phase 2 PRECEDENT Study of Dalzanemdor (SAGE-718) in the Treatment of Mild Cognitive Impairment in Parkinson’s Disease • Business Wire • 04/17/2024 10:30:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM